Background Desmoplastic melanoma (DM) is frequently misdiagnosed clinically and often associated with melanoma
Introduction
Desmoplastic melanoma (DM) is an uncommon type of invasive melanoma, representing <5% of all melanomas.
1,2 DM is characterized histologically by sparsely distributed spindle cells in a fibrocollagenous stroma. 3, 4 In approximately three quarters of DMs, there is an overlying melanoma in situ (MIS) [usually of lentigo maligna (LM) type] or atypical melanocytic hyperplasia. 2, 5 It is important to recognize DM from other types of melanoma for two reasons. Firstly, DM has a different clinical behaviour compared to other types of melanoma, which may influence management decisions. 3, 6 This includes a higher local recurrence rate, and less propensity to metastasize to the regional lymph nodes in DM. 3, 6 These behaviours are influenced by the proportion of the tumour that is desmoplastic. 3, 4 Secondly, DM is commonly associated with large MIS and also commonly occurs in the head and neck region, 2, 5 where cosmesis is a concern. Should partial biopsy be undertaken in such circumstances, site selection must be carefully determined to sample from the region thought most likely to have an invasive melanoma component, so that a DM or other type of invasive melanoma is not missed. This is especially relevant in the context of non-invasive treatments for MIS like radiotherapy or imiquimod, which would not be appropriate on their own for primary invasive melanoma. DM may be difficult to clinically diagnose as they are frequently mistaken for benign lesions or other types of skin cancer. 5 Dermoscopy may provide clues towards a diagnosis of DM, such as atypical vascular structures and peppering. 5, 7 To facilitate accurate diagnosis of DM, we sought to investigate the features of DM with dermoscopy and reflectance confocal microscopy (RCM) and compare them with MIS and other types of invasive melanoma. Our first hypothesis was that dermoscopy could be used to help identify DM (simulating the clinical scenario where dermoscopy is used as a screening tool -so that a biopsy for lesions suspicious of DM then becomes warranted). The second hypothesis was that RCM could be useful to distinguish DM (with or without an in situ component) from MIS, and/or non-DM invasive melanoma (simulating the scenario of when RCM is used to help determine where to biopsy from a suspicious lesion). Our final hypothesis was that, should RCM not be sufficient in clinically distinguishing DM from other melanoma subtypes, RCM could at least be used to determine if the melanoma (irrespective of subtype) is in situ or invasive (to enable a targeted biopsy to the area most likely to be invasive, or prompt complete excision of the lesion).
Methods

Study design and patient recruitment
This was a case-control study taken from data accrued between 2005 and 2015.
DM cases were identified from three different tertiary centres for melanoma diagnosis that included Australia (Melanoma Institute Australia and Sydney Melanoma Diagnostic Centre, Sydney), Spain (Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona) and Italy (Department of Dermatology, University of Modena and Reggio Emilia, Modena).
The study was covered under local governance board and ethics committee approvals from the Royal Prince Alfred Hospital zone of Sydney local area health district (X15-0392), and Hospital Cl ınic de Barcelona (HCB/2014/0023, HCB/2015/ 0146).
A ratio of at least 3 : 1 control cases for each DM was sought. Control cases were other types of melanoma found from a RCM database in Sydney, so that pathology records for these cases could be directly accessed by the first author. The controls were matched to the age (by average of AE5 years) and site location frequency (AE10%) of the DM group. The control group was weighted equally to contain non-DM MIS, and non-DM invasive melanomas. This weighting represented an awareness that DM is commonly associated with MIS 2 , and ensured that our hypotheses could be tested. The non-DM invasive melanomas were selected in a > 1 : 1 proportion by the subtypes of invasive melanoma associated with the DM cases found.
Inclusion and exclusion criteria
The main inclusion criterion was RCM images of a histopathologically confirmed melanoma. Clinical and dermatoscopic images, along with representative histopathological images from all DM cases, were also sought. The exclusion criteria were any melanomas without histopathology after RCM was taken. All patients gave verbal consent for the imaging completed in the study and received no compensation for their participation. RCM imaging in all centres was performed with Vivascope â 1500 or Vivascope â 3000 machines (Caliber Imaging and Diagnostics Inc, Rochester, NY, USA).
Study variables
Patient and lesion details were recorded as noted in Table 1 . DM cases had dermoscopy characteristics recorded according to the study by Jaimes et al. 5 (P.G.). Histopathology images of the DM cases underwent central review by a histopathology team (R.S., A.S.), with the features noted described in Tables 1 and 2 , along with assessment for neurotropia (present or absent) and percentage desmoplasia. Reflectance confocal microscopy characteristics evaluated included those relevant to melanoma defined from previous observations [8] [9] [10] [11] , and other parameters are described in Table 2 .
Dermal inflammation on RCM was defined as 'diffuse single or aggregated small (<12 lm) round-to-polygonal mildly refractive cells at the dermal level'. 12 RCM features were analysed blinded to dermoscopy and histopathology (N.G.M.). The RCM score for melanoma diagnosis 8 was calculated for all lesions in the study, and the LM score 13 was calculated for the MISs.
Data analysis
Statistical analysis was performed using IBM To address our first hypothesis, the frequency of dermatoscopic melanocytic and melanoma-specific features of the DM group were evaluated and compared to those recorded in the DM study by Jaimes et al.
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To address our second hypothesis, exact logistic regression analyses were conducted to examine the association of RCM features to DM compared to the melanoma controls (DM versus all melanoma controls, DM versus non-DM MIS and DM versus non-DM invasive melanoma). Exact logistic regression was used due to the small data set. The same method was also used to compare the association of RCM features between MIS and the combined DM and non-DM invasive group of melanomas.
Descriptive and Cohen K statistics were calculated for RCMhistological agreement between analogous variables assessed for *Three cases missing Breslow depth data. †Two DM cases did not have histopathological slides available for central review. ‡Pure DM ≥90% desmoplasia, mixed desmoplastic melanoma <90% desmoplasia. ALM, acral lentiginous melanoma; DM, desmoplastic melanoma; LMM, lentigo maligna melanoma; LM, lentigo maligna; N/a, not applicable; NR, not recorded; NS, Non-specified; SSM, superficial spreading melanoma. the DM cases. Cohen K statistics were also used to examine the correlation between spindle cells in the superficial dermis on RCM and spindle cells as the predominant cell type found from the invasive melanomas. P values were calculated as two-tailed, and a P value of <0.05 was regarded as significant.
Results
The study demographics and summary histopathological characteristics found for the DM, MIS and non-DM invasive melanomas are shown in Table 1 . The range of Breslow depths for the DM patients with these data available (n = 13) was 1.1-10 mm.
Dermoscopy
For the 15 DM that had dermoscopy available (dermoscopy data were missing for one patient), one had one colour only, two had two colours, and 12 had three or more colours (Fig. 1) 12 were flat with a raised component (of which eight were papules, one was nodular, and three were papular and nodular) and two were raised lesions only (both nodules). All 15 cases demonstrated ill-defined borders. Table 3 shows the frequency of DM dermoscopic features in our series compared with those from the Jaimes et al. 5 study, which is the largest dermoscopy study on DM that the authors are aware of. Table 4 shows the frequency of RCM features recorded in the study. Strong RCM melanoma predictors 8, 10 were commonly found in the DM population (pagetoid cells 100%, cell atypia 75%, nucleated cells in the dermis 75%). Only two melanomas scored <3 on the RCM score (1 DM and 1 MIS -both had scores of 2), giving a 97% sensitivity for melanoma diagnosis with a RCM score of ≥3. For the LM score, four MISs scored <2, giving a sensitivity of 85% for MIS diagnosis in our series at this cutoff. Figure 1 A man in his 70s with a pale nodule and an indurated periphery with brown, pink and red coloration on the left cheek, which revealed a desmoplastic melanoma on wide excision (a). Dermoscopy demonstrates a healing scar from an earlier shave biopsy (that revealed lentigo maligna, white arrow), along with atypical vascular structures, peppering, crystalline structures, annular-granular pattern, pseudonetwork, follicular obliteration and regression areas (b-d). Desmoplastic melanoma detection 
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From the 14 DM cases that had histopathological slides available for central review, the percentage of desmoplasia in the dermal component was 100% for six cases, and <100% for eight cases. Neurotropism was present in four cases. Using these 14 DM cases to test the RCM-histopathological correlation for the five analogous RCM-histological features described in Table 2 , there was no agreement or poor agreement on Cohen K statistics. The percentage of total concordant evaluations (if variables were assessed only as present or absent) was 79% for density of junctional melanocytes, 71% for pigment incontinence, 50% for pagetoid spread, 43% for spindle cells within 0.3 mm of the surface and 36% for dermal inflammation. The RCM presence of spindle cells in the superficial dermis showed moderate correlation with invasive melanomas that featured spindle cells as a predominant cell type, if a predominant cell type was specified or available (n = 34, K = 0.428 P = 0.008).
Discussion
In the largest series describing dermoscopic features of DM (n = 37) by Jaimes et al. 5 , all DM featured at least one melanoma-specific structure, with the most common one being atypical vascular structures (81%). A smaller study (n = 6 DM) also identified one melanoma-specific structure in all DM cases. 7 Our results, which also revealed a melanoma-specific structure on dermoscopy being found in all of our DM cases, validates this earlier research and confirms that dermoscopy may be helpful in guiding the clinician towards a biopsy for lesions that ultimately result in DM diagnosis. Both our study and the Jaimes et al. 5 study found a high prevalence of atypical vascular structures in DM. This seemed to be one of the main differences when compared to general non-specified melanoma populations 14, 15 , which had much lower frequencies of vascular structures. However, this difference could be related to Breslow thickness differences, as this dermoscopic feature became more frequent in the general melanoma population with increasing Breslow thickness (up to 47% for Breslow thickness>0.75 mm 14 ) , and our study had a mean Breslow thickness of 3.3 mm (standard deviation 2.36 mm) in the DM population, and the Jaimes et al. 5 study had a mean Breslow thickness of 3.38 mm in their DM population (range 0.5-12.0 mm). Previous RCM scoring systems developed in larger series for melanoma diagnosis 8 , and LM diagnosis 13 demonstrated similar sensitivities at relevant cut-off scores (≥3 RCM score, ≥2 LM score) to those found in our study. The additional examination of lesions with RCM following dermoscopy may possibly improve the ability to distinguish DM from MIS. While common DM dermoscopy features such as atypical vascular structures and milky-red areas may suggest invasive melanoma over MIS 14, 16 , our findings also suggest that the RCM features of dermal inflammation (Fig. 2) (OR 6.99), in addition to spindle cells in the superficial dermis ( Fig. 3) Univariate analysis indicated that the RCM features of nucleated cells in the dermis and dermal inflammation were both significant to distinguish any invasive type of melanoma from MIS in our series.
While our study showed that spindle cells in the superficial dermis on RCM may provide a clue towards DM diagnosis irrespective of whether the melanoma is in situ or invasive, this feature alone is not reliable, given that it was only detected in 50% of DM cases and may be present with other melanoma invasive subtypes, and also in other types of neoplasms (e.g. Spitz nevi).
Interestingly, spindle cells in the superficial dermis on RCM showed a moderate correlation to spindle cells as the predominant cell type on histopathology within the group of invasive melanomas in our series, but when examined amongst DMs, demonstrated poor correlation to histopathology. This may imply that when spindle cells are more abundant (or less sparsely distributed), the RCM-histopathology correlation improves. In potential support of this, a study on Spitz nevi showed good correlation between spindled cells on RCM and histopathology (n = 40, K = 0.400). 9 In general, there were poor correlations between analogous RCM and histopathological characteristics evaluated amongst the 14 DM cases. This could be attributed to a number of things. Firstly, three of these five features analysed were from the dermis, at the limit of RCM imaging capabilities. Other studies have shown good correlation between RCM and histopathology for melanocytic pathologies under different circumstances, 9,17 but difficulties with correlation in the dermal layer. 18 Secondly, there was no guarantee that RCM images were taken from where the DM was identified histologically within the specimen. While this would be desirable in a prospective study design, because DM is rare, it may be difficult to undertake. Thirdly, it may reflect the small number of DM patients, which could skew the statistics. In addition, a single RCM rater was a limitation of our study. The other limitations of our study included the retrospective design, which did not allow for a standardized protocol for acquisition of RCM images, and that RCM technology has improved over the 10-year accrual period to find these DM cases.
In conclusion, a melanoma-specific structure on dermoscopy, particularly atypical vascular structures, along with recognized RCM features for melanoma (such as pagetoid cells, cell atypia and nucleated cells in the dermis) 8, 10 , is useful for the clinical identification of DM. When the RCM features of dermal inflammation and nucleated cells in the dermis are present, this favours invasive melanoma over MIS. Whereas the presence of abundant spindled cells intermingled with collagen fibres can be considered a specific clue for DM diagnosis, this feature is not always observable, probably because of the limited depth of exploration of RCM. Further studies are required to validate these findings. Should this be the case, these features could be used to aid RCM targeted biopsies and RCM follow-up of MIS treated non-invasively. 
